Justus Duyster - Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany

基本信息

浏览量：149

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 442 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas

Eliza M. Lauer, Ella Riegler,Jurik A. Mutter,Stefan K. Alig,Sabine Bleul,Julia Kuehn,Lavanya Ranganathan, Christian Klingler,Theo Demerath,Urs Wuertemberger,Alexander Rau,Jakob Weiss,

NEURO-ONCOLOGY（2024）

引用0浏览0WOS引用

Conditional survival to assess prognosis in patients with chronic lymphocytic leukemia

Pascal Schlosser, Annett Schiwitza, Jonas Klaus, Stefanie Hieke-Schulz, Katarzyna Szarc vel Szic,Justus Duyster, Martin Trepel,Katja Zirlik, Martin Schumacher,Rainer Claus

Annals of Hematologyno. 5 (2024): 1-10

引用0浏览0WOS引用

A newly identified 45-kDa JAK2 variant with an altered kinase domain structure represents a novel mode of JAK2 kinase inhibitor resistance

Sivahari Prasad Gorantla,Tony Andreas Mueller,Corinna Albers-Leischner,Martina Rudelius,Nikolas von Bubnoff,Justus Duyster

MOLECULAR ONCOLOGYno. 2 (2024): 415-430

引用0浏览0WOS引用

Type II JAK2 Inhibitor CHZ‐868 and HSP90 Inhibitors Are Potent towards the Ruxolitinib Resistant JAK2 Variants in JAK2 Driven Myeloproliferative Neoplasms

Sivahari Prasad Gorantla, Gerin Prince, Jasmin Osius, Dhurvas Dinesh, Vijay Kumar Boddu,Justus Duyster,Nikolas Von Bubnoff

crossref（2024）

引用0浏览0引用

Primary results of patients with genitourinary malignancies presented at a Molecular Tumor Board

Jakob Michaelis, Ruth Himmelsbach,Patrick Metzger,Silke Lassmann, Melanie Börries,Martin Werner,Cornelius Miething, Rouven Höfflin,Anna L Illert,Justus Duyster,Heiko Becker,August Sigle,

Urologia internationalis (2024)

引用0浏览0WOS引用

Supplementary Figures 1-2, Table 1 from FMS-Like Tyrosine Kinase 3–Internal Tandem Duplication Tyrosine Kinase Inhibitors Display a Nonoverlapping Profile of Resistance Mutations <i>In vitro</i>

Nikolas von Bubnoff,Richard A. Engh, Espen Åberg, Jana Sänger,Christian Peschel,Justus Duyster

crossref（2023）

引用0浏览0引用

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response

Petya Apostolova,Stefanie Kreutmair,Cristina Toffalori,Marco Punta,Susanne Unger, Ann-Cathrin Burk,Claudia Wehr,Kristina Maas-Bauer,Wolfgang Melchinger,Eileen Haring,Rouven Hoefflin,Khalid Shoumariyeh,

British journal of haematology (2023)

引用0浏览0WOS引用

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas

Jurik A Mutter,Stefan K Alig,Mohammad S Esfahani,Eliza M Lauer,Jan Mitschke,David M Kurtz,Julia Kühn,Sabine Bleul,Mari Olsen,Chih Long Liu,Michael C Jin,Charles W Macaulay,

J Clin Oncol（2023）

引用17浏览0WOS引用

Efficacy of Jak1/2 inhibition in murine myeloproliferative neoplasms is mediated by targeting nonmalignant cells

Sivahari Prasad Gorantla,Michael Rassner Rassner,Tony Andreas Mueller,Teresa Poggio, Kirstyn Anne Crossley, Anna-Lena Denecke, Kornelia R. Fritsch,Geoffroy Andrieux, Helen Kleinfelder, Shifa Khaja Saleem, Sudheer Madan Mohan Gambheer, Irene Gonzalez Menendez,

ONCOLOGY RESEARCH AND TREATMENT（2023）

引用0浏览0引用

Pixantrone containing R‐CPOP as firstline treatment in elderly DLBCL patients with congestive heart failure or high risk of anthracycline induced cardiotoxicity

Reinhard Marks, K. Lorenz,Martin Trepel,Andreas Rank,Gerald Illerhaus, H. Pelz,Christian W. Scholz,Justus Duyster,Tim Strüßmann

Hematological Oncologyno. S2 (2023): 425-426

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn